
Synopsys (NASDAQ: SNPS) reported third-quarter results below consensus, with revenues of $1.74 billion and adjusted EPS of $3.39 missing analyst expectations, leading to multiple price target reductions from firms like Piper Sandler and KeyBanc, and a downgrade to Neutral by Rosenblatt due to weakness in its intellectual property business. This cautious outlook is further underscored by the Chief Accounting Officer's sale of 15,873 shares for $7.8 million after exercising options, at a time when the stock is noted to be trading above its fair value.
Synopsys (SNPS) is facing a period of heightened scrutiny following a third-quarter earnings report that missed consensus estimates, with revenues of $1.74 billion falling short of the expected $1.77 billion and adjusted EPS of $3.39 missing the $3.80 forecast. This underperformance has triggered a cautious response from the analyst community; while firms like Piper Sandler and KeyBanc maintained 'Buy' or 'Overweight' ratings, they uniformly lowered price targets into a new $550-$630 range. More significantly, Rosenblatt downgraded the stock from 'Buy' to 'Neutral', citing specific weakness in the company's intellectual property (IP) business, which is now identified as a key headwind for future quarters. The reported organic growth of 9% and a $78 million revenue contribution from the Ansys acquisition are overshadowed by these concerns. Compounding the negative sentiment is a notable insider transaction: the Chief Accounting Officer sold 15,873 shares for approximately $7.84 million. Although this sale followed the exercise of options at a low price of $89.76, its timing—coinciding with the earnings miss and an assessment that the stock is trading above its fair value—amplifies the bearish signal, despite the executive's remaining holding of 20,520 shares.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.55
Ticker Sentiment